Search Results 1111-1120 of 38184 for HRT Facts

1. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

   Participating Mayo Clinic info; More information ... Participants requiring hormone replacement with ... Additional contact information. Cancer-related ...

2. Women's Wellness: Vaginal atrophy after breast cancer - Mayo Clinic News Network

   Systemic hormone therapy generally isn't recommended. And cancers that are ... Find more health and medical information on mayoclinic.org. Making ...

3. Frequently asked questions - Chicago - Mayo Clinic

   You don't have to be seriously ill to seek care at Mayo. In fact, patients travel to Mayo Clinic from every state in the U.S. and more than 140 countries around ...

4. Treatment of an Inherited Ventricular Arrhythmia - Mayo Clinic

   Thyroid hormone replacement medication may be ... information regarding possible participation. ... D. Closed for enrollment. More information. Publications.

5. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Rochester, Minn. Mayo Clinic principal investigator. Andrea Wahner Hendrickson, M.D.. Contact information: Cancer Center Clinical Trials Referral Office. (855) ...

6. Medical Research & Education - Mayo Clinic News Network

   Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early- ...

7. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

8. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

   - Hormone-replacement therapy or oral contraceptives - ... physiologic hormone replacement may be eligible. ... Additional contact information. Cancer-related ...

9. Medical Research & Education - Mayo Clinic News Network

   ROCHESTER, Minn. — A medication commonly used to treat overactive bladder significantly reduced hot flashes in men receiving hormone therapy for prostate ...

10. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

    Medical records research — uses historical information ... NOTE: Concomitant hormone replacement therapy is allowed. ... Additional contact information. Cancer- ...